Your browser doesn't support javascript.
loading
A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer.
Zhang, Yang; Wang, Zi-Xian; Shen, Lin; Li, Jin; Huang, Jing; Su, Wei-Guo; Zhang, Dong-Sheng; Xu, Rui-Hua.
Afiliação
  • Zhang Y; Department of Clinical Research, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
  • Wang ZX; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Shen L; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, P. R. China.
  • Li J; Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Huang J; Department of Gastrointestinal Oncology, Beijing Cancer Hospital, Beijing, P. R. China.
  • Su WG; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Shanghai, P. R. China.
  • Zhang DS; Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, P. R. China.
  • Xu RH; HUTCHMED limited, Shanghai, P. R. China.
Cancer Commun (Lond) ; 43(1): 150-153, 2023 01.
Article em En | MEDLINE | ID: mdl-36331272

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica Limite: Humans Idioma: En Revista: Cancer Commun (Lond) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica Limite: Humans Idioma: En Revista: Cancer Commun (Lond) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos